FTX, the collapsed crypto exchange alleged to be a political money laundering operation, is listed as the financial backer of an infamous study used to ‘discredit’ ivermectin.
The study, published by the New England Journal of Medicine (NEJM), declared ivermectin to be an ineffective remedy against COVID-19.
In May, the FTX Foundation issued a press release “proudly” announcing financial support for the “global expansion of the TOGETHER Trial.”
PRNewswire reported:
The FTX Foundation proudly announces financial support for the global expansion of the TOGETHER Trial on the same day that the trial investigators receive the prestigious Trial of the Year Award from the Society for Clinical Trials (SCT) in San Diego.
Each year the SCT presents one award for a randomized clinical trial published the previous year that best exemplifies five key criteria including…
